Baumer S.A (BALM3) fair value: what the stock is really worth
As of Nov 4, 2026: fair value (intrinsic value) of Baumer S.A stock BRL 40.65, price BRL 22.00, upside +84.8%, quality 71 out of 100. Rating: strongly undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Baumer S.A
BALM3 · SACheap (46% below fair value), solid company and rising price: meets all 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 15, 2026.
How to read this chart
60‑month range R$3.70 – R$30.00 · fair‑value band R$30.48 – R$50.81 · the R$22.00 price screens below the R$40.65 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 15, 2026.
Every Wednesday you see whether Baumer is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Baumer S.A., together with its subsidiaries, engages in the development, industrialization, trade, production, import, export, and technical assistance in products for hospitals and industries related to the health area in Brazil and internationally.
Show moreShow less
The company offers orthopedic devices, such as conventional prosthesis, spine and neurosurgery, non-conventional prosthesis, trauma, and biomaterials; and hospital equipment, including CSSD, surgical center and ICU, and sterilization process monitoring.
It also provides life science equipment comprising pharmaceutical production and research laboratory; bone regeneration consisting of structural, raw material, and specialties; and maintenance, sterilization process monitoring, rental, CME equipment management, technological update, and replacement parts, as well as inspection, qualification, and calibration services.
In addition, the company offers the Baumer Academy platform for specialized courses in the areas of hospital equipment, bone regeneration, and orthopedic devices. Baumer S.A. was incorporated in 1952 and is headquartered in Pacaembu, Brazil.
Stock analysis
Baumer S.A (BALM3) currently trades at R$22.00, while our model-based Fair Value estimate is R$40.65, implying the stock looks roughly 46% undervalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of R$82.75 per share, and 23 of the 26 models we run sit above the R$22.00 price.
Bear case: the Asset-Based group reads lowest at R$8.16, and 3 of the 26 models stay below the price. Data coverage for this calculation is medium.
Scenario range: R$30.48 (bear) to R$50.81 (bull), the price of R$22.00 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 71/100 (solid quality), in the Healthcare sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Baumer S.A reported revenue of R$214M in FY2025 versus R$268M in FY2021, a compound −5.5%/yr. Reported net income was R$18.1M in FY2025, compounding +15.6%/yr from FY2021.
Key figures
Market cap R$215M (≈ $37.1M) Micro · P/E ratio 10.1 · P/S ratio 1.05 · EPS (TTM) R$2.18 · Net margin 11.0% · Return on equity 14.8% · Return on assets (EBIT) 8.7% (5-year average) · Operating margin 14.1%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 56 out of 100 (low confidence).
What moves the price
The share trades about 27% below its 52-week high and 10% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −44% fair-value upside, at 85%, BALM3 screens cheaper than that median.
Fair Value models
All 26 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
Watch BALM3, get fair value alerts →
Compare Baumer S.A with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 199 stocks
Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- P/S ratio by industry
- EBIT margin by industry
- Stock screener with 62 metrics
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Solventum Corporation SOLV | $86.06 | $131.27 | +53% | vs BALM3 |
| EssilorLuxottica Société anonyme EL | €180.80 | €196.22 | +9% | vs BALM3 |
| Intuitive Surgical, Inc ISRG | $430.53 | $353.90 | −18% | vs BALM3 |
| Medline Inc MDLN | $37.68 | $28.59 | −24% | vs BALM3 |
| Alcon Inc ALC | CHF 62.32 | CHF 35.08 | −44% | vs BALM3 |
| Becton, Dickinson and Company BDX | $215.42 | $97.80 | −55% | vs BALM3 |
| Straumann Holding STMN | CHF 107.90 | CHF 45.50 | −58% | vs BALM3 |
| West Pharmaceutical Services, Inc WST | $414.12 | $139.22 | −66% | vs BALM3 |
| Sartorius Stedim Biotech S.A DIM | €226.80 | €54.82 | −76% | vs BALM3 |
| Sartorius Aktiengesellschaft SRT | €229.50 | €46.44 | −80% | vs BALM3 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Baumer S.A (BALM3) overvalued or undervalued?
What is the fair value of BALM3?
What is the quality score of BALM3?
What is the price target for Baumer S.A (BALM3)?
What is the Baumer S.A stock forecast for 2026?
What is the revenue of Baumer S.A (BALM3)?
What growth is priced into Baumer S.A (BALM3)?
What discount rate (WACC) does the fair value of BALM3 use?
What is a reverse DCF?
How much growth has Baumer S.A (BALM3) delivered so far?
How fast is the sector of Baumer S.A (BALM3) growing?
What is the free cash flow yield of Baumer S.A (BALM3)?
What is the intrinsic value of Baumer S.A (BALM3)?
Is Baumer S.A stock overvalued or undervalued in 2026?
Is fair value the same as the market price of BALM3?
How much is Baumer S.A worth?
What do the bullish and bearish scenarios say about BALM3?
What is the P/E ratio of BALM3?
How solid is the balance sheet of Baumer S.A (BALM3)?
How far is BALM3 from its 52-week high?
Which stocks are comparable to Baumer S.A?
Is Baumer S.A stock attractive at the current price?
How is the fair value of BALM3 calculated?
Is it still worth investing in stocks now?
What is the share price of Baumer S.A (BALM3)?
What should I pay attention to with Baumer S.A right now?
Where does the earnings growth of Baumer S.A (BALM3) come from?
Key figures of Baumer S.A
How large is the market capitalisation of Baumer S.A (BALM3)?
What is the P/S ratio of Baumer S.A (BALM3)?
What are the earnings per share of Baumer S.A (BALM3)?
What is the net margin of Baumer S.A (BALM3)?
What is the return on equity of Baumer S.A (BALM3)?
What is the EBIT return on assets of Baumer S.A (BALM3)?
What is the operating margin of Baumer S.A (BALM3)?
How fast is revenue growing at Baumer S.A (BALM3)?
How fast are earnings growing at Baumer S.A (BALM3)?
How much net debt does Baumer S.A (BALM3) carry?
Watch Baumer S.A in the live analysis
One click puts Baumer S.A on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.